Almhagen, E.; Alkhiat, A.; Sorcini, B.; Alpsten, F.; Kronborg, C.J.S.; Rønde, H.S.; Guren, M.G.; Pilskog, S.; Valdman, A.
An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer. Cancers 2025, 17, 2627.
https://doi.org/10.3390/cancers17162627
AMA Style
Almhagen E, Alkhiat A, Sorcini B, Alpsten F, Kronborg CJS, Rønde HS, Guren MG, Pilskog S, Valdman A.
An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer. Cancers. 2025; 17(16):2627.
https://doi.org/10.3390/cancers17162627
Chicago/Turabian Style
Almhagen, Erik, Ali Alkhiat, Bruno Sorcini, Freja Alpsten, Camilla J. S. Kronborg, Heidi S. Rønde, Marianne G. Guren, Sara Pilskog, and Alexander Valdman.
2025. "An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer" Cancers 17, no. 16: 2627.
https://doi.org/10.3390/cancers17162627
APA Style
Almhagen, E., Alkhiat, A., Sorcini, B., Alpsten, F., Kronborg, C. J. S., Rønde, H. S., Guren, M. G., Pilskog, S., & Valdman, A.
(2025). An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer. Cancers, 17(16), 2627.
https://doi.org/10.3390/cancers17162627
